Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00541502|
Recruitment Status : Unknown
Verified October 2007 by Genovate Biotechnology Co., Ltd.,.
Recruitment status was: Not yet recruiting
First Posted : October 10, 2007
Last Update Posted : October 10, 2007
|Condition or disease|
|Study Type :||Observational|
|Official Title:||A Obervational, Prospective Study to Evaluate the Effectiveness of Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder in Taiwan|
|Study Start Date :||November 2007|
|Estimated Study Completion Date :||October 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00541502
|Principal Investigator:||Chen Chih-Ken, PhD||Chang Gung Memorial Hospital, Keelung, Taiwan|